Invesco
PHAT icon

Invesco’s Phathom Pharmaceuticals PHAT Stock Holding History

Invesco’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48M Buy
4,322,060
+401,614
+10% +$5.07M ﹤0.01% 1088
2025
Q4 		$65M Buy
3,920,446
+55,475
+1% +$792K 0.01% 988
2025
Q3 		$45.5M Sell
3,864,971
-275,101
-7% -$2.84M 0.01% 1119
2025
Q2 		$39.7M Buy
4,140,072
+489,260
+13% +$2.71M 0.01% 1153
2025
Q1 		$22.9M Sell
3,650,812
-20,574
-0.6% -$125K ﹤0.01% 1369
2024
Q4 		$29.8M Sell
3,671,386
-425,376
-10% -$5.27M 0.01% 1296
2024
Q3 		$74.1M Buy
4,096,762
+953,310
+30% +$13.3M 0.01% 890
2024
Q2 		$32.4M Sell
3,143,452
-16,337
-0.5% -$168K 0.01% 1202
2024
Q1 		$33.6M Sell
3,159,789
-7,864
-0.2% -$66.8K 0.01% 1211
2023
Q4 		$28.9M Sell
3,167,653
-251,306
-7% -$2.17M 0.01% 1237
2023
Q3 		$35.5M Buy
3,418,959
+86,822
+3% +$1.19M 0.01% 1096
2023
Q2 		$47.7M Buy
3,332,137
+1,150,465
+53% +$13.3M 0.01% 965
2023
Q1 		$15.6M Sell
2,181,672
-25,977
-1% -$228K ﹤0.01% 1480
2022
Q4 		$24.8M Buy
2,207,649
+139,781
+7% +$1.44M 0.01% 1271
2022
Q3 		$22.9M Buy
2,067,868
+21,062
+1% +$201K 0.01% 1241
2022
Q2 		$17.3M Sell
2,046,806
-2,953
-0.1% -$30.4K 0.01% 1464
2022
Q1 		$27.9M Sell
2,049,759
-17,597
-0.9% -$284K 0.01% 1288
2021
Q4 		$40.7M Buy
2,067,356
+71,340
+4% +$1.68M 0.01% 1139
2021
Q3 		$64.1M Sell
1,996,016
-25,384
-1% -$844K 0.02% 956
2021
Q2 		$68.4M Sell
2,021,400
-7,531
-0.4% -$270K 0.02% 954
2021
Q1 		$76.2M Sell
2,028,931
-25,507
-1% -$1.07M 0.02% 904
2020
Q4 		$68.2M Sell
2,054,438
-25,749
-1% -$1.04M 0.02% 915
2020
Q3 		$76.3M Sell
2,080,187
-15,256
-0.7% -$528K 0.03% 746
2020
Q2 		$69M Buy
2,095,443
+19,758
+1% +$759K 0.02% 765
2020
Q1 		$53.6M Sell
2,075,685
-26,618
-1% -$890K 0.02% 767
2019
Q4 		$65.5M Buy
+2,102,303
New +$52.8M 0.02% 874

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return